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stimulated HOC). Although the levels of RANKL were increased
for all the doses of PGE2 tested, compared to unstimulated HOC,
the amount of RANKL anchored to cell membrane was inversely
proportional to the amount of PGE2 in the culture medium, with a
peak at 10-8M PGE2 (20-fold vs. unstimulated HOC). 11-Deoxy-
PGE1, an EP2/EP4 agonist, reproduced PGE2 actions on OPG
and RANKL expression. Butaprost, a selective EP2 agonist was
less potent than PGE2. Sulprostone, an EP1/EP3 agonist, had
no effect on OPG or RANKL expressions. An inhibitor of adeny-
late cyclase completely abolished the up-regulation of OPG and
RANKL exerted by PGE2, pointing to an EP2/EP4 dependent
signalling pathway, that requires cAMP for this action.
Conclusions: The activation of EP2/EP4 receptors up-regulated
the expression and synthesis of OPG and, to a signiﬁcantly
higher extent, those of RANKL in HOC. These data suggest that
PGE2, a key mediator in the development of OA, could regulate
in vivo the expression and the release of the key mediators of
bone metabolisms by articular chondrocytes. This mechanism,
still unknown, would allow the chondrocytes to control the activity
of subchondral bone cells.
16
GENOME-WIDE LINKAGE SCAN ON A LARGE
ICELANDIC COHORT WITH HIP AND KNEE
OSTEOARTHRITIS
T. Ingvarsson1, H. Jonsson2, V.B. Hauksson3,
K. Kristjánsson3, H. Pétursson3, K. Stefansson3
1University Hospital Akureyri, Iceland, Akureyri, Iceland;
2University Hospital Reykjavik, Iceland, Reykjavik, Iceland;
3Decode Genetics, Reykjavik, Iceland
Purpose: To identify susceptibility loci for hip and knee os-
teoarthritis.
Abstract 16 – Figure 1. Results from a genome-wide linkage scan using 281 families with 819 patients with total hip replacement associated with OA.
Background: Osteoarthritis (OA) is the most common form
of musculoskeletal disability in the developed countries. Risk
factors associated with hip and knee OA include age, heavy
labour, sports and genetic factors. We present the ﬁrst reported
genome-wide linkage scan of total knee replacement (TKR)
associated with OA, and genome-wide linkage scan results for
total hip replacement (THR) associatied with OA.
Methods: We performed a genome-wide linkage scan with a
framework set of 1662 microsatellite markers using a) 281 ex-
tended Icelandic families with 819 unique patients (357 males
and 462 females) with THR associated with hip OA, and b)
124 extended Icelandic families with 334 unique patients (133
males and 201 females) with TKR associated with knee OA.
The families were identiﬁed by cross-matching a list of patients
with a genealogy database of the entire Icelandic population1.
The patients in each family were related at or within 4 meioses.
All study subjects signed an informed consent and underwent
comprehensive phenotype examination.
Results: No linkage peaks reached genome-wide signiﬁcance
for either THR or TKR.
We detected suggestive linkage of THR to chromosome 3p12.1
with an allele-sharing LOD score of 2.5 (marker D3S1276, at
108.5 cM) (see Fig. 1). Suggestive linkage of TKR to chromo-
some 4q21.23 was observed with a LOD score of 2.0 (marker
D4S395, at 117.9 cM) (see Fig. 2). No other linkage peaks with
LOD scores higher than 2.0 were found for either THR or TKR.
Conclusions: The suggestive linkage on chromosome 4 is cen-
tred on 4q21.3 and is restricted to patients with TKR for OA.
Loughlin et al.2 reported a linkage peak on 4q12-4q21 with a
LOD score of 3.1 in female patients with THR for OA. No link-
age was found in this region when we did the analysis using
female patients only. We are not aware of any other published
suggestion of linkage on chromosome 3 for THR patients with
hip OA. Our results will be followed by genome-wide association
studies.
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Abstract 16 – Figure 2. Results from a genome-wide linkage scan using 124 families with 334 patients with total knee replacement associated with OA.
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Purpose: Osteoarthritis (OA) of the knee has an increasing
public health impact in aging populations. Combinations of genes
have shown potential to identify individuals at high risk of disease.
However, to date the discovery of novel genetic risk factors for
knee OA using large-scale genome-wide association methods
has not been undertaken.
Methods: In this study the allele frequencies of 550,000 mark-
ers from the HumanHap550 Whole-Genome Genotyping from
pooled genomic DNA from 713 female knee OA cases and 569
controls were calculated. Data for markers in common with the
HumanHap300-Duo Genotyping BeadChip were combined with
individual genotypes for 100 knee OA cases and 500 controls
(all female).
Results: Preliminary analyses indicated that genes part of pro-
apoptotic signaling, in the Wnt signaling and Smad signaling
pathways that had not previously shown to be involved in OA
were associated with disease risk. For the ten markers with
the smallest p-values, all showing genome-wide signiﬁcance,
two or more SNPs in the same gene region were selected and
genotyped individually for the original 813 cases plus additional
540 cases and for the original 1069 controls plus additional 1040
controls.
Conclusions: We present the combined results of the discovery
and replication samples in the largest genetic association study
of knee OA in women to date.
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Purpose: Osteoarthritis (OA) is the most common bone and
joint disease. Genetic factors have been implicated in its etiology
and pathogenesis. Growth and differentiation factor 5 (GDF5)
is a growth factor that belongs to a subgroup of the TGF-
β/BMP family. GDF5 has been implicated in chondrogenesis,
joint formation and OA. The aim of the study is to clarify the role
of GDF5 in the etiology and pathogenesis of OA using combined
approach of human and mouse genetics.
Methods: Human study. A case-control association study on
GDF5 was performed for OA of the knee and hip joints in
Japanese using several independent cohorts including a total
of more than 3,500 subjects (1,000 hip OA, 718 knee OA and
1,845 control). A susceptibility gene was located by a linkage-
disequilibrium mapping. The replication of the association was
examined in a Han Chinese knee OA population. The allelic
difference of the associated sequence variation was evaluated
by in vitro functional studies.
Mouse study. Through a large-scale ENU mutagenesis screen,
a mouse mutant with Gdf5 mutation was identiﬁed. This mouse
carries an amino acid substitution (W408R) in a highly conserved
